查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1591869

荷尔蒙补充疗法市场：按类型、给药途径- 2025-2030 年全球预测

Hormone Replacement Therapy Market by Type (Estrogen Replacement Therapy, Growth Hormone Replacement Therapy, Thyroid Hormone Replacement Therapy), Route of Administration (Oral, Parenteral, Transdermal) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年荷尔蒙补充疗法市值为258.3亿美元，预计到2024年将达到280.4亿美元，复合年增长率为8.66%，到2030年将达到462.1亿美元。

荷尔蒙补充疗法(HRT) 是治疗方法。 HRT 最初是为了缓解女性更年期症状而开发的，现已扩展到治疗内分泌失调，现在包括生物同质和合成选项。 HRT的需求在于缓解荷尔蒙缺乏和失衡引起的症状，透过解决潮热、骨质疏鬆、性慾低下和情绪低落等问题，有效提高患者的生活品质。其应用涵盖医疗机构、诊所和家庭，并透过针对更年期患者和荷尔蒙缺乏或性别转变需求的患者进一步多样化。寿命的延长、更年期症状发生率的增加以及荷尔蒙健康意识的增强正在推动市场成长。不断变化的性别认同和不断扩大的抗衰老治疗应用正在开闢新的途径。蓬勃发展的个人化医疗领域及其客製化 HRT 的潜力提供了巨大的市场机会。然而，市场面临监管审查、潜在副作用和高昂治疗成本等障碍，这可能会抑制消费者信心和接受度。此外，来自替代疗法和自然疗法的竞争也带来了额外的挑战。创新应着重于提高治疗的安全性和有效性，正在进行的植物来源的生物同质激素和用于个人化剂量和监测的数位健康技术的研究尤其有前途。投资消费者教育和宣传宣传活动也可以加速接受。市场动态表明，这是一个竞争激烈但蓬勃发展的细分市场，其特征是技术进步和不断增长的人口需求。透过对研发的策略性投资以及专注于以患者为中心的综合解决方案来应对这些复杂性，公司可以成功进入不断扩大的 HRT 市场。为了获得持久的客户忠诚度和市场占有率成长，重点应放在安全性、有效性和解决更广泛的患者问题上。

主要市场统计
基准年[2023] 258.3亿美元
预测年份 [2024] 280.4亿美元
预测年份 [2030] 462.1亿美元
复合年增长率（%） 8.66%

市场动态：揭示快速发展的荷尔蒙补充疗法市场的关键市场洞察

供需的动态交互作用正在改变荷尔蒙补充疗法市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 世界人口荷尔蒙失衡加剧
    • 提高对更年期征兆和治疗方案的认识
    • 增加荷尔蒙疗法的药物传输系统
  • 市场限制因素
    • 治疗费用上涨
  • 市场机会
    • 使用生物同质製剂的荷尔蒙补充疗法
    • 创新性新推出荷尔蒙补充疗法仪
  • 市场问题
    • 荷尔蒙补充疗法对健康的不良影响

波特五力：驾驭荷尔蒙补充疗法市场的策略工具

波特的五力框架是了解荷尔蒙补充疗法市场竞争格局的关键工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解荷尔蒙补充疗法市场的外部影响

外部宏观环境因素在塑造荷尔蒙补充疗法市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解荷尔蒙补充疗法市场的竞争格局

对荷尔蒙补充疗法市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：荷尔蒙补充疗法市场供应商的绩效评估

FPNV定位矩阵是评估荷尔蒙补充疗法市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製荷尔蒙补充疗法市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，荷尔蒙补充疗法市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界人口中荷尔蒙失衡疾病的增加
      • 提高对更年期征兆和治疗方法的认识
      • 增加荷尔蒙疗法的药物传输系统
    • 抑制因素
      • 治疗费用高
    • 机会
      • 采用生物同质荷尔蒙补充疗法
      • 创新推出荷尔蒙补充疗法设备
    • 任务
      • 荷尔蒙补充疗法对健康的不良影响
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章荷尔蒙补充疗法市场：按类型

  • 介绍
  • 雌激素替代疗法
  • 生长激素荷尔蒙补充疗法
  • 甲状腺荷尔蒙补充疗法

第七章荷尔蒙补充疗法市场：依给药途径

  • 介绍
  • 口服
  • 胃肠外的
  • 经皮的

第八章美洲荷尔蒙补充疗法市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太荷尔蒙补充疗法市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲荷尔蒙补充疗法市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Amgen Inc.
  • Bayer AG
  • Eli Lilly and Company
  • Endo International PLC
  • Genentech, Inc.
  • Merck KGaA
  • Mithra Pharmaceuticals
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Transcend Company Inc.
  • Viatris Inc.
  • Wellnexio LLC
Product Code: MRR-43127F7278AB

The Hormone Replacement Therapy Market was valued at USD 25.83 billion in 2023, expected to reach USD 28.04 billion in 2024, and is projected to grow at a CAGR of 8.66%, to USD 46.21 billion by 2030.

Hormone Replacement Therapy (HRT) is a medical treatment aimed at augmenting or replacing hormones that the body no longer produces sufficiently. Initially developed to ease menopausal symptoms in women, HRT has expanded to treat endocrine disorders and now includes bioidentical and synthetic options. The necessity of HRT revolves around mitigating symptoms of hormone deficiency or imbalance, effectively enhancing patients' quality of life by addressing hot flashes, osteoporosis, low libido, and mood swings. Its application spans across healthcare facilities, clinics, and homes, diversified further by targeting both menopausal individuals and those with hormonal deficiencies or gender transition needs. Market growth is fueled by increased longevity, rising menopause occurrences, and greater awareness of hormonal health. Evolving gender identity views and expanding applications in anti-aging treatments are opening fresh avenues. Personalized medicine, a burgeoning aspect with potential for tailored HRT, offers noteworthy market opportunities. However, the market faces obstacles such as regulatory scrutiny, potential side effects, and high therapy costs, possibly impeding consumer trust and uptake. Furthermore, competition from alternative therapies and natural remedies presents additional challenges. Innovations should focus on enhancing therapy safety and efficacy, with ongoing research into plant-based bioidentical hormones and digital health tech for personalized dosing and monitoring being particularly promising. Investment in consumer education and awareness campaigns can also accelerate acceptance. Market dynamics suggest a competitive yet thriving space marked by technological advancements and a growing demographic imperative. By navigating these complexities with strategic investments in R&D and focusing on comprehensive patient-oriented solutions, businesses can successfully tap into the expanding HRT market. The emphasis should be on safety, efficacy, and addressing broader patient concerns to capture enduring customer loyalty and market share expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 25.83 billion
Estimated Year [2024] USD 28.04 billion
Forecast Year [2030] USD 46.21 billion
CAGR (%) 8.66%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hormone Replacement Therapy Market

The Hormone Replacement Therapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing hormonal imbalance disorders in global population
    • Growing awareness about menopausal signs and the treatment options
    • Rise in drug delivery systems for hormone therapy
  • Market Restraints
    • High cost of treatment
  • Market Opportunities
    • Introduction of bioidentical hormone replacement therapy
    • Innovative new launches of devices for hormone replacement therapy
  • Market Challenges
    • Adverse health effects of hormone replacement therapy

Porter's Five Forces: A Strategic Tool for Navigating the Hormone Replacement Therapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hormone Replacement Therapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Hormone Replacement Therapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hormone Replacement Therapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Hormone Replacement Therapy Market

A detailed market share analysis in the Hormone Replacement Therapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hormone Replacement Therapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hormone Replacement Therapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Hormone Replacement Therapy Market

A strategic analysis of the Hormone Replacement Therapy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hormone Replacement Therapy Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amgen Inc., Bayer AG, Eli Lilly and Company, Endo International PLC, Genentech, Inc., Merck KGaA, Mithra Pharmaceuticals, Novartis AG, Novo Nordisk A/S, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Transcend Company Inc., Viatris Inc., and Wellnexio LLC.

Market Segmentation & Coverage

This research report categorizes the Hormone Replacement Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Estrogen Replacement Therapy, Growth Hormone Replacement Therapy, and Thyroid Hormone Replacement Therapy.
  • Based on Route of Administration, market is studied across Oral, Parenteral, and Transdermal.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing hormonal imbalance disorders in global population
      • 5.1.1.2. Growing awareness about menopausal signs and the treatment options
      • 5.1.1.3. Rise in drug delivery systems for hormone therapy
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of bioidentical hormone replacement therapy
      • 5.1.3.2. Innovative new launches of devices for hormone replacement therapy
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse health effects of hormone replacement therapy
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Hormone Replacement Therapy Market, by Type

  • 6.1. Introduction
  • 6.2. Estrogen Replacement Therapy
  • 6.3. Growth Hormone Replacement Therapy
  • 6.4. Thyroid Hormone Replacement Therapy

7. Hormone Replacement Therapy Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Oral
  • 7.3. Parenteral
  • 7.4. Transdermal

8. Americas Hormone Replacement Therapy Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Hormone Replacement Therapy Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Hormone Replacement Therapy Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Amgen Inc.
  • 3. Bayer AG
  • 4. Eli Lilly and Company
  • 5. Endo International PLC
  • 6. Genentech, Inc.
  • 7. Merck KGaA
  • 8. Mithra Pharmaceuticals
  • 9. Novartis AG
  • 10. Novo Nordisk A/S
  • 11. Pfizer Inc.
  • 12. Teva Pharmaceutical Industries Ltd.
  • 13. Transcend Company Inc.
  • 14. Viatris Inc.
  • 15. Wellnexio LLC

LIST OF FIGURES

  • FIGURE 1. HORMONE REPLACEMENT THERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. HORMONE REPLACEMENT THERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. HORMONE REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. HORMONE REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HORMONE REPLACEMENT THERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HORMONE REPLACEMENT THERAPY MARKET DYNAMICS
  • TABLE 7. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ESTROGEN REPLACEMENT THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GROWTH HORMONE REPLACEMENT THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THYROID HORMONE REPLACEMENT THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. HORMONE REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. HORMONE REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2023